• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Cytokine Signature Associated With Disease Severity in COVID-19

tetano

Editor, Senior Moderator
Front Immunol


. 2021 Aug 20;12:681516.
doi: 10.3389/fimmu.2021.681516. eCollection 2021.
Cytokine Signature Associated With Disease Severity in COVID-19


Jing Guo[SUP] 1 [/SUP], Shuting Wang[SUP] 1 [/SUP], He Xia[SUP] 1 [/SUP], Ding Shi[SUP] 1 [/SUP], Yu Chen[SUP] 1 [/SUP], Shufa Zheng[SUP] 1 [/SUP], Yanfei Chen[SUP] 1 [/SUP], Hainv Gao[SUP] 2 [/SUP], Feifei Guo[SUP] 2 [/SUP], Zhongkang Ji[SUP] 1 [/SUP], Chenjie Huang[SUP] 1 [/SUP], Rui Luo[SUP] 1 [/SUP], Yan Zhang[SUP] 1 [/SUP], Jian Zuo[SUP] 1 [/SUP], Yunbo Chen[SUP] 1 [/SUP], Yan Xu[SUP] 1 [/SUP], Jiafeng Xia[SUP] 1 [/SUP], Chunxia Zhu[SUP] 1 [/SUP], Xiaowei Xu[SUP] 1 [/SUP], Yunqing Qiu[SUP] 1 [/SUP], Jifang Sheng[SUP] 1 [/SUP], Kaijin Xu[SUP] 1 [/SUP], Lanjuan Li[SUP] 1 2 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) broke out and then became a global epidemic at the end of 2019. With the increasing number of deaths, early identification of disease severity and interpretation of pathogenesis are very important. Aiming to identify biomarkers for disease severity and progression of COVID-19, 75 COVID-19 patients, 34 healthy controls and 23 patients with pandemic influenza A(H1N1) were recruited in this study. Using liquid chip technology, 48 cytokines and chemokines were examined, among which 33 were significantly elevated in COVID-19 patients compared with healthy controls. HGF and IL-1β were strongly associated with APACHE II score in the first week after disease onset. IP-10, HGF and IL-10 were correlated positively with virus titers. Cytokines were significantly correlated with creatinine, troponin I, international normalized ratio and procalcitonin within two weeks after disease onset. Univariate analyses were carried out, and 6 cytokines including G-CSF, HGF, IL-10, IL-18, M-CSF and SCGF-β were found to be associated with the severity of COVID-19. 11 kinds of cytokines could predict the severity of COVID-19, among which IP-10 and M-CSF were excellent predictors for disease severity. In conclusion, the levels of cytokines in COVID-19 were significantly correlated with the severity of the disease in the early stage, and serum cytokines could be used as warning indicators of the severity and progression of COVID-19. Early stratification of disease and intervention to reduce hypercytokinaemia may improve the prognosis of COVID-19 patients.

Keywords: COVID-19; SARS-CoV-2; biomarker; disease severity; hypercytokinaemia.
 
Back
Top Bottom